Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 10.92 HKD -0.73% Market Closed
Market Cap: 23.2B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Income Statement

Earnings Waterfall
Genscript Biotech Corp

Revenue
1B USD
Cost of Revenue
-468.1m USD
Gross Profit
541.5m USD
Operating Expenses
-936.5m USD
Operating Income
-395m USD
Other Expenses
218m USD
Net Income
-177m USD

Income Statement
Genscript Biotech Corp

Rotate your device to view
Income Statement
Currency: USD
Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
87
N/A
99
+14%
115
+16%
125
+9%
153
+22%
201
+32%
231
+15%
241
+4%
273
+14%
318
+16%
391
+23%
454
+16%
490
+8%
570
+16%
626
+10%
712
+14%
840
+18%
1 010
+20%
Gross Profit
Cost of Revenue
(30)
(33)
(39)
(42)
(48)
(58)
(72)
(85)
(93)
(108)
(135)
(168)
(208)
(258)
(322)
(409)
(430)
(468)
Gross Profit
57
N/A
66
+16%
76
+15%
83
+9%
105
+26%
143
+37%
159
+11%
156
-2%
180
+16%
210
+16%
256
+22%
286
+12%
283
-1%
312
+11%
304
-3%
304
0%
410
+35%
541
+32%
Operating Income
Operating Expenses
(37)
(40)
(50)
(53)
(67)
(107)
(150)
(206)
(304)
(371)
(462)
(567)
(805)
(912)
(736)
(761)
(797)
(937)
Selling, General & Administrative
(46)
(48)
(51)
(54)
(65)
(78)
(78)
(98)
(126)
(145)
(198)
(236)
(304)
(356)
(352)
(374)
(393)
(424)
Research & Development
0
0
0
0
0
(28)
(74)
(109)
(186)
(239)
(263)
(323)
(358)
(361)
(390)
(420)
(433)
(462)
Depreciation & Amortization
(0)
(0)
(0)
(0)
(0)
(1)
(2)
0
0
0
0
0
0
0
0
0
0
0
Other Operating Expenses
9
8
1
1
(2)
(0)
4
3
8
13
(1)
(8)
(142)
(195)
6
34
28
(51)
Operating Income
20
N/A
26
+34%
26
+0%
30
+13%
38
+26%
36
-4%
9
-76%
(50)
N/A
(124)
-146%
(161)
-30%
(206)
-28%
(281)
-36%
(522)
-86%
(600)
-15%
(432)
+28%
(457)
-6%
(387)
+15%
(395)
-2%
Pre-Tax Income
Interest Income Expense
3
5
6
5
1
4
15
17
12
8
8
7
5
3
1
4
52
137
Non-Reccuring Items
0
0
0
0
0
0
(1)
0
(2)
(82)
(80)
0
0
0
0
0
(12)
(49)
Total Other Income
0
0
0
0
0
0
0
0
0
0
(4)
0
0
0
(1)
(1)
(3)
(5)
Pre-Tax Income
23
N/A
31
+36%
33
+4%
34
+6%
39
+12%
40
+4%
23
-43%
(34)
N/A
(114)
-239%
(235)
-107%
(282)
-20%
(274)
+3%
(517)
-89%
(597)
-15%
(432)
+28%
(454)
-5%
(351)
+23%
(312)
+11%
Net Income
Tax Provision
(5)
(6)
(6)
(6)
(12)
(10)
(2)
3
(4)
(10)
0
(3)
(1)
1
4
6
(4)
(13)
Income from Continuing Operations
18
25
27
28
27
30
21
(30)
(118)
(245)
(281)
(277)
(518)
(596)
(428)
(448)
(355)
(325)
Income to Minority Interest
0
0
(0)
(1)
(1)
(3)
0
9
21
62
76
94
160
193
201
259
260
148
Net Income (Common)
18
N/A
25
+43%
26
+5%
28
+7%
26
-7%
27
+2%
21
-20%
(22)
N/A
(97)
-348%
(183)
-88%
(205)
-12%
(183)
+11%
(359)
-96%
(403)
-12%
(227)
+44%
(189)
+17%
(95)
+50%
(177)
-85%
EPS (Diluted)
0.01
N/A
0.02
+100%
0.02
N/A
0.02
N/A
0.02
N/A
0.01
-50%
0.01
N/A
-0.01
N/A
-0.05
-400%
-0.1
-100%
-0.11
-10%
-0.09
+18%
-0.18
-100%
-0.19
-6%
-0.11
+42%
-0.09
+18%
-0.05
+44%
-0.08
-60%

See Also

Discover More